Prospective Clinical Evaluation of the FilmArray® NGDS Warrior Panel

Inclusion criteria

* Whole blood (prospectively collected via informed consent): * Adult subject has a recorded or self-reported fever within the previous 24 hours * Subject provides informed consent prior to enrollment and specimen collection * Subject has not previously provided a whole blood specimen for this study Whole blood (residual) * Whole blood (in EDTA) submitted to laboratory for standard of care testing * Specimen is not from an individual with a specimen previously enrolled in the study Positive Blood Culture: * Culture was detected as positive by an automated blood culture system * Culture is not from a patient previously enrolled in the study Negative Blood Culture: * Culture not detected as positive by an automated blood culture system * Culture is not from a patient previously enrolled in the study Sputum: * Specimen was accepted for testing by the respective site's microbiology laboratory * Specimen is not from an individual that has a sputum already enrolled in the study